CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823523180
- Phone
- 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- 4 Planned sale 10% owner sold 141,927 shares at an average $0.96 ($136,855)
- 4 Planned sale Director sold 125,576 shares at an average $0.92 ($115,234)
- 4 Planned sale 10% owner sold 195,666 shares at an average $0.92 ($179,551)
- 4 Planned sale 10% owner sold 195,666 shares at an average $0.92 ($179,551)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 102,753 shares at an average $0.92 ($94,930)
- 4 Planned sale 10% owner sold 160,103 shares at an average $0.92 ($147,913)
- 4 Planned sale 10% owner sold 160,103 shares at an average $0.92 ($147,913)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Planned sale Director sold 134,553 shares at an average $0.96 ($128,785)
- 4 Planned sale 10% owner sold 209,652 shares at an average $0.96 ($200,665)
- 4 Planned sale 10% owner sold 209,652 shares at an average $0.96 ($200,665)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 8 of 23 · 453 filings